RNLX

Q: What is the price of Renalytix (RNLX) today?

The price of Renalytix (RNLX) today is $ 0.00, with return of 0% compared to the last year. The price of Renalytix (RNLX) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Renalytix (RNLX) and international markets.

Q: When does Renalytix (RNLX) pay dividends?

Renalytix (RNLX) did not distribute dividends in the last year.

Q: Is Renalytix (RNLX) worth it?

Currently, Renalytix (RNLX) is priced at $ 0.00, with a P/E of -0.40%, representing a deviation of -23,462% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Renalytix (RNLX) stock?

Investing in stocks of Renalytix (RNLX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Renalytix (RNLX) yield today?

The yield of Renalytix (RNLX) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Renalytix (RNLX) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Renalytix AI PLC

Price

$ -

return (12m)

0.00%

p/e

-0.40

p/bv

-1.72

DIVIDEND YIELD

0.00%

price RNLX

RNLX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of RNLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals RNLX

review the fundamentals of Renalytix shares

P/E

-0.40

Sector: -2.36 Industry: 2.15

P/SALES RATIO (PSR)

5.89

Sector: 2.07 Industry: 0.69

P/BV

-1.72

Sector: 2.24 Industry: 1.97

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-419.69%

Sector: -27.36% Industry: -12.35%

ROE

426.10%

Sector: -30.63% Industry: -23.95%

ROIC

-191.92%

Sector: -416.26% Industry: -111.32%

NET MARGIN

-100.00%

Sector: -28.68% Industry: -11.07%

GROSS MARGIN

6.79%

Sector: 43.81% Industry: 31.35%

OPERATING MARGIN

-100.00%

Sector: -24.80% Industry: -8.00%

P/EBITDA

-0.72

Sector: -0.47 Industry: 2.63

P/EBIT

-0.67

Sector: -2.70 Industry: 0.96

P/ASSET

1.70

Sector: 1.22 Industry: 0.79

BVPS

-0.11

Sector: 3.31 Industry: 5.64

EPS

-0.48

Sector: -0.91 Industry: -0.27

EQUITY RATIO

-0.98

Sector: 0.42 Industry: 0.28

CAGR REVENUE 5 YEARS

41.86%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

9.13%

Sector: - Industry: -

Fundamentals RNLX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	49.22	38.00	77.20%	0.57%	$ 906.25 B	30.99%
ISRG	74.77	12.05	16.12%	0.00%	$ 205.40 B	28.58%
TMO	32.95	4.23	12.84%	0.29%	$ 216.51 B	15.02%
SNY	10.77	1.50	13.90%	4.47%	$ 121.40 B	14.83%
MDT	27.28	0.00	0.00%	2.78%	$ 129.94 B	13.71%
NVS	17.68	5.69	32.16%	2.93%	$ 254.54 B	25.53%
ABT	16.07	4.38	27.26%	1.83%	$ 224.54 B	31.88%
CVS	204.64	1.31	0.64%	3.52%	$ 95.97 B	0.12%
GSK	13.26	4.55	34.29%	3.43%	$ 96.81 B	17.23%
BSX	51.76	0.00	0.00%	0.00%	$ 144.52 B	14.43%
TMDX	50.58	13.07	25.84%	0.00%	$ 4.64 B	16.20%
HCA	17.88	-52.52	-293.84%	0.58%	$ 113.40 B	8.53%
IDXX	55.60	36.59	65.81%	0.00%	$ 57.13 B	24.65%
INMD	6.07	1.39	22.89%	0.00%	$ 908.46 M	41.04%
DHR	45.92	3.15	6.86%	0.54%	$ 160.86 B	14.43%
RMD	26.05	6.12	23.49%	0.85%	$ 37.46 B	27.35%
FMS	16.64	0.83	5.00%	3.39%	$ 13.58 B	3.73%
PHG	114.23	2.07	1.81%	3.28%	$ 25.72 B	1.14%
SYK	47.25	6.38	13.51%	0.92%	$ 139.06 B	12.07%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RNLX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Renalytix

Renalytix AI PLC

Average user rating I10

4.0 (0 people)

United States

7 years

Founded: 2018

2020

Time since IPO - 5 years

9

Employees

The Company Renalytix AI PLC (United States), is listed on Nasdaq with a market value of $ 13.52 Millions, having an equity of $ -7.85 Millions.

With a total of 9 employees, the company is listed in the sector of Health and categorized in industry of Health Technology.

In the last 12 months the Company had a revenue of $ 2.30 Millions, which generated a loss in the amount of $ -33.45 Millions.

As for its main indicators, the Company has a P/E ratio of -0.40, a P/BV ratio of -1.72 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker RNLX.

Market cap

$ 13.52 Millions

Net worth

$ -7.85 Millions

US$ -7,850,000.00

Assets

$ 7.97 Millions

US$ 7,970,000.00

Total Shares Outstanding

69.00 Millions

69,000,000

Average Daily Trading Volume

$ 804.39 Thousand

US$ 804,388.90

Sector

Health

Industry

Health Technology

RNLX

RNLX revenue and profits

Financial Results RNLX

DRAG THE FRAME TO SEE MORE DATA

RNLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.42 67,75% (12M)

P/E

204.64

3.52%

ROE

0.64%

P/BV

1.31

CI - Cigna

$ 274.70 --0,12% (12M)

P/E

11.49

2.23%

ROE

14.63%

P/BV

1.68

CNC - Centene

$ 40.85 --31,25% (12M)

P/E

-3.56

0.00%

ROE

-25.12%

P/BV

0.89

HUM - Humana

$ 268.45 --0,35% (12M)

P/E

23.97

1.37%

ROE

6.95%

P/BV

1.67

SNY - Sanofi

$ 48.68 8,63% (12M)

P/E

10.77

4.47%

ROE

13.90%

P/BV

1.50

HCA - HCA Healthcare

$ 484.77 58,11% (12M)

P/E

17.88

0.58%

ROE

-293.84%

P/BV

-52.52

LLY - Eli Lilly

$ 1,027.51 32,88% (12M)

P/E

49.22

0.57%

ROE

77.20%

P/BV

38.00